One Page Case Studies Announces Report on Success Story Writing for Landscapers
Success story content marketing specialist One Page Case Studies announces a new report analyzing how…
Month: September 2023
Overview of Honda Exhibits at the JAPAN MOBILITY SHOW 2023
TOKYO, Sep 26, 2023 – (JCN Newswire) – Honda booth image*Note: Vehicles/exhibits shown in these…
Zayo Supercharges Connectivity With Fully-Enabled 400G European Network
Enhanced network expands capacity and scalability to support global bandwidth demands BOULDER, Colo.–(BUSINESS WIRE)–Zayo Group,…
Nardello & Co. Continues Global Expansion with New Leadership in EMEA
LONDON & DUBAI, United Arab Emirates & NEW YORK–(BUSINESS WIRE)–Nardello & Co., the global investigations…
OpenX Announces ConteX, the Next Generation of Contextual Solutions for Brands and Agencies to Target Ad Campaigns Safely, Effectively, and at Scale
ConteX represents the future of contextual buying by delivering effective targeting, contract-free activation, and broader…
OpenX Announces ConteX, the Next Generation of Contextual Solutions for Brands and Agencies to Target Ad Campaigns Safely, Effectively, and at Scale
ConteX represents the future of contextual buying by delivering effective targeting, contract-free activation, and broader…
OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board
PRESS RELEASE OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board Oxford, United Kingdom…
Press Release: Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for FDA Priority Review
Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11…
Dupixent® (dupilumab) sBLA for Treatment of Eosinophilic Esophagitis (EoE) in Children Aged 1 to 11 Accepted for FDA Priority Review
If approved, Dupixent would be the first and only treatment in the U.S. indicated for…
Sandoz receives European Commission approval for Tyruko® (natalizumab), first and only biosimilar for multiple sclerosis in Europe
Biosimilar Tyruko® approved for all indications of reference medicine, as first and only biosimilar to…
NMD Pharma initiates Phase II trial of NMD670 in Spinal Muscular Atrophy
NMD Pharma initiates Phase II trial of NMD670 in Spinal Muscular Atrophy Aarhus, Denmark, 26…
Mithra Financial Results for First-Half 2023
Mithra Financial Results for First-Half 2023 Good progress on strategy to strengthen balance sheet and…
Fujitsu launches new technologies to protect conversational AI from hallucinations and adversarial attacks
TOKYO, Sep 26, 2023 – (JCN Newswire) – Figure 1. Overview of trusted conversational AINewly…
Bollywood Sensation Javed Ali to Mesmerize Singapore with a Spectacular Musical Extravaganza at Esplanade Concert
SINGAPORE, Sept 26, 2023 – (ACN Newswire) – Get ready to be enchanted by the…
Accounting & Finance Show Asia Sets to Welcome Regional Accounting, Finance and Business Leaders for its Biggest Edition
SINGAPORE, Sept 26, 2023 – (ACN Newswire) – The Accounting & Finance Show Asia, the…
Vicinity Showcased Cloud Native and Time Sensitive 5G Networking Solutions at Mobile World Congress Americas 2023
LAS VEGAS–(BUSINESS WIRE)–Vicinity Technologies Limited (Vicinity) showcases the advanced 5G cloud-native and time-sensitive networking solutions…
Immunovant to Host Conference Call and Webcast to Report Initial IMVT-1402 Phase 1 Results on September 26, 2023
NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology…
Fujitsu and iSurgery launch bone health promotion project in Japan with Jikei University School of Medicine aiming for early detection of osteoporosis
TOKYO, Sep 26, 2023 – (JCN Newswire) – Image of analysis and inspection by AI…
Take Victory and Defend Your Well-being with LAC Legends(TM)
Singapore, Sept 26, 2023 – (ACN Newswire) – Get ready to take your focus, coordination,…
Eftsure Releases Comprehensive Guide on How Effective Financial Controls Can Mitigate Cyber Fraud
SYDNEY, AUSTRALIA / ACN Newswire / September 26, 2023 / The Latitude Financial, Optus and…